|
1
|
Basu P, Jenkins H, Tsang K and Vakharia
VN: National survey of neurosurgeons and stroke physicians on
decompressive hemicraniectomy for malignant middle cerebral artery
infarction. World Neurosurg. 102:320–328. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Friedrich B, Lobsien D, Maegerlein C,
Wunderlich S, Zimmer C, Kaesmacher J and Kleine J: Distance to
Thrombus in acute middle cerebral artery stroke predicts basal
ganglia infarction after mechanical thrombectomy. Oncotarget.
7:85813–85818. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu Y, Tang G, Li Y, Wang Y, Chen X, Gu X,
Zhang Z, Wang Y1 and Yang GY: Metformin attenuates blood-brain
barrier disruption in mice following middle cerebral artery
occlusion. J Neuroinflammation. 11:1772014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bujak R, Błażejewski J, Biedermann A,
Sinkiewicz W, Karasek D, Banach J and Dobosiewicz M: Severe,
thromboembolic pulmonary hypertension with recurrent pulmonary
embolism and right heart thrombi in a patient with past myocardial
infarction, cerebral ischaemic stroke and small intestine necrosis.
Kardiol Pol. 69:61–66. 2011.(In Polish). PubMed/NCBI
|
|
5
|
De Schryver EL and Halkes PH: No role for
oral anticoagulants (target INR: 2.0-3.0) after transient ischaemic
attack or cerebral infarction of arterial origin; the
‘European/Australasian stroke prevention in reversible ischaemia
trial’ (ESPRIT). Ned Tijdschr Geneeskd. 152:445–453. 2008.(In
Dutch). PubMed/NCBI
|
|
6
|
Kleindorfer D, Lindsell CJ, Brass L,
Koroshetz W and Broderick JP: National US estimates of recombinant
tissue plasminogen activator use: ICD-9 codes substantially
underestimate. Stroke. 39:924–928. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y, Huang Y, Xu Y, Ruan W, Wang H,
Zhang Y, Saavedra JM, Zhang L, Huang Z and Pang T: A Dual AMPK/Nrf2
activator reduces brain inflammation after stroke by enhancing
microglia M2 polarization. Antioxid Redox Signal. 28:141–163. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qiu J, Wang M, Zhang J, Cai Q, Lu D, Li Y,
Dong Y, Zhao T and Chen H: The neuroprotection of Sinomenine
against ischemic stroke in mice by suppressing NLRP3 inflammasome
via AMPK signaling. Int Immunopharmacol. 40:492–500. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen H, Liu H, Zou H, Chen R, Dou Y, Sheng
S, Dai S, Ai J, Melson J, Kittles RA, et al: Evaluation of plasma
miR-21 and miR-152 as diagnostic biomarkers for common types of
human cancers. J Cancer. 7:490–499. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang LM, Wang YJ, Cui M, Luo WJ, Wang XJ,
Barber PA and Chen ZY: A dietary polyphenol resveratrol acts to
provide neuroprotection in recurrent stroke models by regulating
AMPK and SIRT1 signaling, thereby reducing energy requirements
during ischemia. Eur J Neurosci. 37:1669–1681. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Garcia-Prieto CF, Hernández-Nuño F, Rio
DD, Ruiz-Hurtado G, Aránguez I, Ruiz-Gayo M, Somoza B and
Fernández-Alfonso MS: High-fat diet induces endothelial dysfunction
through a down-regulation of the endothelial AMPK-PI3K-Akt-eNOS
pathway. Mol Nutr Food Res. 59:520–532. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Han F, Guo Y, Xu L, Hou N, Han F and Sun
X: Induction of haemeoxygenase-1 directly improves endothelial
function in isolated aortas from obese rats through the
Ampk-Pi3k/Akt-Enos pathway. Cell Physiol Biochem. 36:1480–1490.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han L, Yu Y, Sun X and Wang B: Exendin-4
directly improves endothelial dysfunction in isolated aortas from
obese rats through the cAMP or AMPK-eNOS pathways. Diabetes Res
Clin Pract. 97:453–460. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao B, Kilic E, Baumann CR, Hermann DM and
Bassetti CL: Gamma-hydroxybutyrate accelerates functional recovery
after focal cerebral ischemia. Cerebrovasc Dis. 26:413–419. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kamal RM, van Noorden MS, Franzek E,
Dijkstra BA, Loonen AJ and De Jong CA: The neurobiological
mechanisms of gamma-hydroxybutyrate dependence and withdrawal and
their clinical relevance: A review. Neuropsychobiology. 73:65–80.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liechti ME, Quednow BB, Liakoni E,
Dornbierer D, von Rotz R, Gachet MS, Gertsch J, Seifritz E and
Bosch OG: Pharmacokinetics and pharmacodynamics of
γ-hydroxybutyrate in healthy subjects. Br J Clin Pharmacol.
81:980–988. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lavyne MH, Hariri RJ, Tankosic T and
Babiak T: Effect of low dose gamma-butyrolactone therapy on
forebrain neuronal ischemia in the unrestrained, awake rat.
Neurosurgery. 12:430–434. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vergoni AV, Ottani A, Botticelli AR, Zaffe
D, Guano L, Loche A, Genedani S, Gessa GL and Bertolini A:
Neuroprotective effect of gamma-hydroxybutyrate in transient global
cerebral ischemia in the rat. Eur J Pharmacol. 397:75–84. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang C, Wang H, Zhang S, Cheng Y and Sun
J: Neuroprotective effects of NKN on focal cerebral ischemia in
rats. Turk Neurosurg. 22:1–6. 2012.PubMed/NCBI
|
|
20
|
Zhang X, Chen L, Dang X, Liu J, Ito Y and
Sun W: Neuroprotective effects of total steroid saponins on
cerebral ischemia injuries in an animal model of focal
ischemia/reperfusion. Planta Med. 80:637–644. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang HT, Zhang P, Gao Y, Li CL, Wang HJ,
Chen LC, Feng Y, Li RY, Li YL and Jiang CL: Early VEGF inhibition
attenuates blood-brain barrier disruption in ischemic rat brains by
regulating the expression of MMPs. Mol Med Rep. 15:57–64. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ran QQ, Chen HL, Liu YL, Yu HX, Shi F and
Wang MS: Electroacupuncture preconditioning attenuates ischemic
brain injury by activation of the adenosine monophosphate-activated
protein kinase signaling pathway. Neural Regen Res. 10:1069–1075.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen L, Wang X, Zhang J, Dang C, Liu G,
Liang Z, Huang G, Zhao W and Zeng J: Tongxinluo enhances
neurogenesis and angiogenesis in peri-infarct area and
subventricular zone and promotes functional recovery after focal
cerebral ischemic infarction in hypertensive rats. Evid Based
Complement Alternat Med. 2016:85495902016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Q, Sanai N, Jin WN, La Cava A, Van
Kaer L and Shi FD: Neural stem cells sustain natural killer cells
that dictate recovery from brain inflammation. Nat Neurosci.
19:243–252. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bellenchi GC, Volpicelli F, Piscopo V,
Perrone-Capano C and di Porzio U: Adult neural stem cells: An
endogenous tool to repair brain injury? J Neurochem. 124:159–167.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Christie KJ and Turnley AM: Regulation of
endogenous neural stem/progenitor cells for neural repair-factors
that promote neurogenesis and gliogenesis in the normal and damaged
brain. Front Cell Neurosci. 6:702013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yao Y, Zheng XR, Zhang SS, Wang X, Yu XH,
Tan JL and Yang YJ: Transplantation of vascular endothelial growth
factor-modified neural stem/progenitor cells promotes the recovery
of neurological function following hypoxic-ischemic brain damage.
Neural Regen Res. 11:1456–1463. 2016.PubMed/NCBI
|
|
28
|
Ma Y, Bu J, Dang H, Sha J, Jing Y,
Shan-jiang AI, Li H and Zhu Y: Inhibition of adenosine
monophosphate-activated protein kinase reduces glial cell-mediated
inflammation and induces the expression of Cx43 in astroglias after
cerebral ischemia. Brain Res. 1605:1–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nam HG, Kim W, Yoo DY, Choi JH, Won MH,
Hwang IK, Jeong JH, Hwang HS and Moon SM: Chronological changes and
effects of AMP-activated kinase in the hippocampal CA1 region after
transient forebrain ischemia in gerbils. Neurol Res. 35:395–405.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gasbarrino K, Zheng H, Hafiane A, Veinot
JP, Lai C and Daskalopoulou SS: Decreased adiponectin-mediated
signaling through the AdipoR2 pathway is associated with carotid
plaque instability. Stroke. 48:915–924. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rockberg J, Jørgensen L, Taylor B, Sobocki
P and Johansson G: Risk of mortality and recurrent cardiovascular
events in patients with acute coronary syndromes on high intensity
statin treatment. Prev Med Rep. 6:203–209. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu JW, Deng YP, Han X, Ren GF, Cai J and
Jiang GJ: Metformin improves the angiogenic functions of
endothelial progenitor cells via activating AMPK/eNOS pathway in
diabetic mice. Cardiovasc Diabetol. 15:882016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang C, Liao Y, Li Q, Chen M, Zhao Q,
Deng R, Wu C, Yang A, Guo Z, Wang D and He X: Recombinant
adiponectin ameliorates liver ischemia reperfusion injury via
activating the AMPK/eNOS pathway. PLoS One. 8:e663822013.
View Article : Google Scholar : PubMed/NCBI
|
